FIGURE

Fig. 7

ID

ZDB-FIG-171206-51

Publication

Chang et al., 2017 - Ftr82 Is Critical for Vascular Patterning during Zebrafish Development

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

Regulation between ftr82 and VEGFR2/Notch. (A,B) ftr82 expression in vessels and CVP is reduced in VEGFR2-specific inhibitor SU5416 (10 μM)-treated embryos ((B), dashed arrow and hollow arrowhead) as compared to DMSO control embryos ((A), arrow and arrowhead); (A,C) ftr82 expression is down-regulated after treatment with Notch inactivation chemical DAPT (75 μM) ((C), dashed arrow and hollow arrowhead) as compared to DMSO control embryos (A); (D) Quantification of the relative expression level by qPCR assay showed the reduced expression of ftr82 in SU5416-treated (0.3 ± 0.18) or DAPT-treated (0.2 ± 0.1) embryos; (D’) qPCR assay showed the relative expression of ftr82 in SU5416-treated (0.5 ± 0.1), GS4012-treated (1.5 ± 0.1), or VEGF-treated (1.1 ± 0.1) embryos; (E–G) Embryos treated with 10 μM SU5416 or 75 μM DAPT showed ISV growth defects and ISV mispatterns, respectively, but vascular structure did not disappear. *** refers to p < 0.0001 and ** refers to p < 0.001 by an unpaired Student's t-test. Data are represented as means ± S.D. Scale bars represent 200 μm in (A–C,E–G).

Expression Data

Gene:	ftr82
Fish:	WT
Conditions:	chemical treatment by environment: DAPT chemical treatment by environment: semaxanib
Anatomical Terms:	caudal vein plexus vasculature
Stage:	Prim-5

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	WT
Conditions:	chemical treatment by environment: DAPT chemical treatment by environment: semaxanib
Observed In:	caudal vein plexus vasculature
Stage:	Prim-5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.